Utilizing the Michigan Neuropathy Screening Instrument for Early Detection of Diabetic Neuropathy

Sohag University100 enrolled

Overview

The study aims to Compare the diagnostic accuracy of the Michigan Neuropathy Screening Instrument (MNSI) (using MNS questionnaire, ,Inspection, vibratory sensation, Ankle reflexes Exam, 10 g monofilament needle examination), routine NCS, and the U/S of the median, posterior tibial, and sural nerves in identifying diabetic peripheral neuropathy in patients recently diagnosed with type 2 diabetes.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Diabetic Polyneuropathy

Eligibility

Sex: ALLMin age: 33 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ü Age: 30-55 y ü Type of diabetes: Type 2 ü Duration of diabetes: Within 1Year of diagnosis of Type 2 diabetes mellitus according to World Health Organization 1999 criteria Exclusion Criteria: * Patients who had known conditions that could present with neuropathy such as hereditary sensory neuropathy, vitamin B12 or folate deficiency, paraneoplastic conditions, autoimmune diseases, uremia, hypothyroidism, and ethanol abuse.

Locations (1)

Faculty of medecine Sohag university

Sohag, Egypt

RECRUITING

Outcomes

Primary Outcomes

Early detection of Diabetic Neuropathy

Utilizing the Michigan Neuropathy Screening Instrument, routine nerve conduction study, and nerve ultrasound for early detection of Diabetic Neuropathy

Time frame: Searching in patients diagnosed within 1 year or less

Central Contacts

Reda Khalaf Allah Khalil, Resident

CONTACT

0102 006 5913 redakhalaf@med.sohag.edu.eg

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.